Scott C Russell

US Patent:

6958074, Oct 25, 2005

Filed:

Jan 7, 2002

Appl. No.:

10/040817

Inventors:

Scott Russell - San Jose CA, US

Assignee:

Cordis Corporation - Miami Lakes FL

International Classification:

A61M029/00

US Classification:

606200, 600585

Abstract:

A releasable and retrievable vascular filter system comprising a filter, a porous filter membrane attached to the filter, and an anti-migration feature for causing the filter to remain substantially stationary in the lumen of the vessel during the clinical procedure. The releasable and retrievable vascular filter system minimizes or substantially eliminates filter movement during the procedure, which may result in damage to the lumen, and/or the release of embolic particulates captured within the filter. The releasable and retrievable vascular filter system also allows for guidewire exchanges, which may be necessary for successful completion of the clinical procedure.

US Patent:

6976983, Dec 20, 2005

Filed:

Jun 12, 2003

Appl. No.:

10/459969

Inventors:

Scott M. Russell - San Jose CA, US

Assignee:

Cordis Corporation - Miami Lakes

International Classification:

A61K009/22
A61F013/00

US Classification:

6048911, 424422

Abstract:

An implantable device for delivering a drug includes a housing and a source of drug contained within the housing. An orifice mechanism is located at the housing and communicates with the source of drug. The orifice mechanism includes an inner member having a proximal end and a distal end and a winding helically wound around the inner member. The winding and the inner member define a first channel for carrying the drug therethrough. An inlet is at the proximal end of the winding and an outlet is at the distal end of the winding. The drug is carried by the orifice mechanism and dispensed outside of the housing.

US Patent:

7108762, Sep 19, 2006

Filed:

Jun 12, 2003

Appl. No.:

10/460554

Inventors:

Scott M. Russell - San Jose CA, US

Assignee:

Cordis Corporation - Miami Lakes FL

International Classification:

B65H 81/00
A61K 9/22
A61F 13/00

US Classification:

156172, 6048911, 424422

Abstract:

A method for manufacturing an orifice mechanism includes the steps of providing a mandrel having a length and helically wrapping a winding around at least a portion of the length of the mandrel. The mandrel and the winding define a first channel for carrying a drug therethrough. An inlet is at one end of the winding and an outlet is at the other end of the winding.

US Patent:

7211076, May 1, 2007

Filed:

Jun 12, 2003

Appl. No.:

10/459959

Inventors:

Scott M. Russell - San Jose CA, US

Assignee:

Cordis Corporation - Miami Lakes FL

International Classification:

A61K 9/22

US Classification:

6048921

Abstract:

A device for delivering a drug includes a body having a proximal end and a distal end and an opening in the distal end thereof. An orifice mechanism at the distal end of the body communicates with the opening. The orifice mechanism includes an inner member having a proximal end and a distal end; a winding helically wound around the inner member; and wherein the winding and the inner member define a first channel for carrying a drug therethrough. An inlet is at the proximal end of the winding and an outlet is at the distal end of the inner member.

US Patent:

7678103, Mar 16, 2010

Filed:

Jun 12, 2003

Appl. No.:

10/460460

Inventors:

Scott M. Russell - San Jose CA, US

Assignee:

Cordis Corporation - Miami Lakes FL

International Classification:

A61K 9/22

US Classification:

6048911, 6048921

Abstract:

An orifice device for delivering a drug includes an inner member having a proximal end and a distal end. A winding is helically wound around the inner member. The winding and the inner member define a first channel for carrying a drug therethrough. An inlet is at the proximal end of the winding and an outlet is at the distal end of the winding.

US Patent:

7811274, Oct 12, 2010

Filed:

Apr 27, 2004

Appl. No.:

10/832905

Inventors:

Don Tanaka - Saratoga CA, US
Scott M. Russell - San Jose CA, US

Assignee:

Portaero, Inc. - Cupertino CA

International Classification:

A61M 31/00

US Classification:

604502, 604523, 604506

Abstract:

A ventilation bypass system which alleviates symptoms of chronic obstructive pulmonary disease by allowing air to exit the lung of a patient through the thoracic wall bypassing the natural airways. A pleurodesis is formed between the visceral and parietal membranes surrounding a lung and an opening is made through the thoracic wall into the lung via the pleurodesis. The ventilation bypass system includes a conduit placed through the opening in the thoracic wall into the lung, a flange for securing the conduit to the thoracic wall and preventing over-insertion of the conduit, and a flow control device for controlling flow of material out of the lung.

US Patent:

7828789, Nov 9, 2010

Filed:

Apr 7, 2008

Appl. No.:

12/098815

Inventors:

Don Tanaka - Saratoga CA, US
Scott M. Russell - San Jose CA, US

Assignee:

Portaero, Inc. - Cupertino CA

International Classification:

A61M 31/00

US Classification:

604506, 128898

Abstract:

The invention provides methods and devices for creating a localized pleurodesis between the thoracic wall and the lung such that a ventilation bypass conduit may be introduced into the lung through the thoracic wall and visceral membrane without causing a pneumothorax. A medical device such as a catheter is used to enter the pleural cavity and deliver a pleurodesis agent to a localized area between the visceral and parietal membranes.

US Patent:

7935098, May 3, 2011

Filed:

Mar 31, 2008

Appl. No.:

12/059607

Inventors:

Michelle Bartning - Fremont CA, US
Mari Hou - Hoboken NJ, US
Kirsten Freislinger Luehrs - Palo Alto CA, US
Scott M. Russell - San Jose CA, US
Paul B. Swick - Lebanon NJ, US
Pramod Mavinkurve - Princeton NJ, US

Assignee:

McNeil-PPC, Inc. - Skillman NJ

International Classification:

A61F 13/15
A61F 13/20

US Classification:

60438517, 604 13, 604904

Abstract:

An applicator for intravaginal devices includes an elongate handle, an insertion sleeve, and an intravaginal device support member. The elongate handle has an open first end that defines a cavity extending into the handle. The insertion sleeve extends from the open first end of the handle; it is arranged and configured to slide into the cavity of the handle and to accommodate an intravaginal device; and it has associated therewith a trigger. The intravaginal device support member is disposed in the cavity of the handle; it is operatively connected to the handle; and it has a bearing surface disposed proximate the open first end of the handle. The applicators are useful to ensure that intravaginal devices are placed in the appropriate position to be effective.